Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Mobile Infrastructure Q1 2026 Earnings Call - Same-Location NOI Grows 4.4% as Asset Rotation and Expense Discipline Offset Flat Revenue
Mobile Infrastructure delivered a solid first quarter in 2026, with same-location NOI growing 4.4% year-over-year to $4.6 million despite flat same-location revenue. The growth came from active expens...
- Same-location NOI grew 4.4% year-over-year to $4.6 million, driven by expense discipline and lease-to-management agreement conversions despite flat same-location revenue.
- Contract parking volumes increased 6% year-over-year, with notable growth in Cincinnati (+24%), Cleveland (+19%), and Fort Worth (+10%).
- Portfolio utilization rose approximately 8 percentage points year-over-year, with the portion of assets above 80% utilization increasing by 750 basis points.
- +13 more takeaways
Dolphin Entertainment {Q1} 2026 Earnings Call - Adjusted EBITDA Loss Narrows 25% as Capital-Light Ventures and Lease Savings Drive Cash Flow Inflection
Dolphin Entertainment reported a 5.2% revenue increase to $12.8 million in Q1 2026, but the market’s attention is shifting from top-line growth to the company’s accelerating cash flow trajectory. Adju...
- Total revenue grew 5.2% year-over-year to $12.8 million, reflecting steady top-line momentum despite Q1’s traditional seasonal weakness.
- Adjusted EBITDA loss narrowed 25% to $467,000, driven by operational efficiency and the exclusion of $1.6 million in one-time costs including legal fees and a distribution guarantee.
- Management highlighted a strategic pivot away from aggressive M&A toward capital-light ventures, including a DealMaker partnership targeting six-figure marketing fees per deal and a zero-capital publishing imprint with Copper Books and Simon & Schuster yielding 15% revenue share.
- +7 more takeaways
Sixth Street Specialty Lending Q1 2026 Earnings Call - NAV Decline Driven by Unrealized Losses from Credit Spread Widening, Dividend Cut to $0.42 to Reflect Sustainable Earnings Power
Sixth Street Specialty Lending reported a first-quarter net loss per share of $0.27, primarily due to unrealized losses on its debt and equity portfolios as credit spreads widened and market multiples...
- Net investment income of $0.42 per share, but net loss per share of $0.27 driven by unrealized losses from wider credit spreads and lower market multiples.
- Net asset value per share declined 4.3% to $16.24, with $0.58 per share ($0.40 debt, $0.18 equity) from non-cash fair value adjustments.
- Base dividend reduced from $0.46 to $0.42 per share to align with sustainable earnings power amid muted activity-based fees and market uncertainty.
- +7 more takeaways
UroGen Pharma Q1 2026 Earnings Call - ZUSDURI Revenue Surges Past $29M as Commercial Launch Accelerates
UroGen Pharma delivered a Q1 2026 revenue beat driven by a 100%+ quarter-over-quarter jump in ZUSDURI sales, now at $29.2 million, as the permanent J-code implementation in January cleared reimburseme...
- ZUSDURI revenue reached $29.2 million in Q1 2026, representing more than 100% quarter-over-quarter growth following the January permanent J-code implementation.
- Total company revenue rose 152% year-over-year to $51 million, driven by ZUSDURI launch momentum and steady JELMYTO sales.
- Unique prescribers for ZUSDURI expanded to 256, up from 102 at year-end, while repeat prescribers grew to 103 from 32, signaling sustained adoption beyond initial launch excitement.
- +9 more takeaways
International General Insurance Holdings Ltd Q1 2026 Earnings Call - Discipline Wins in a War-Torn Market
International General Insurance Holdings delivered a resilient Q1 2026, posting a 35.1% jump in underwriting income to $37.7 million and a 89.1% combined ratio, despite absorbing $15 million in net lo...
- Underwriting income surged 35.1% year-over-year to $37.7 million, driving a 89.1% combined ratio that beats Q1 2025 by 5.3 points and aligns with long-term averages.
- Gross written premiums declined 4.5% to $197.2 million as the company proactively exited two reinsurance programs to protect margins in a softening market.
- Middle East conflict losses contributed 19.2 points to the combined ratio, including a $15 million net hit from political violence and a $10.5 million indirect energy loss in the Persian Gulf.
- +7 more takeaways
ACI Worldwide Q1 2026 Earnings Call - Connetic Drives Renewals and Real-Time Payments Fuel Growth
ACI Worldwide delivered a strong start to 2026 with 6% organic revenue growth in constant currency and 12% year-over-year adjusted EBITDA growth. The company raised full-year guidance, citing robust d...
- Q1 2026 revenue reached $426 million, up 8% year-over-year and 6% in constant currency, marking the strongest Q1 start since the company’s inception.
- Adjusted EBITDA grew 12% to $105 million, with margins expanding nearly 200 basis points to 38%, driven by operational efficiency and software leverage.
- New ARR bookings surged 39% to $12 million, led by the Biller segment, where Speedpay One is capturing share from legacy platforms in utilities, insurance, and government.
- +12 more takeaways
Tapestry Q3 2024 Earnings Call - Coach's 'Expressive Luxury' Strategy Fuels Record Growth and Raises Outlook
Tapestry delivered a standout third quarter, with pro forma revenue growing 23% and EPS jumping 62%, driven primarily by an exceptional performance at Coach. The brand successfully expanded its 'expre...
- Pro forma revenue grew 23% in constant currency, with EPS up 62% to $1.66, exceeding all expectations and allowing Tapestry to raise its full-year outlook.
- Coach delivered exceptional results with 29% constant currency revenue growth, driven by the acquisition of 2 million new customers and strong Gen Z retention.
- The 'expressive luxury' strategy is gaining traction globally, with double-digit growth in North America (27%), Europe (27%), and Greater China (58%).
- +9 more takeaways
The Carlyle Group Q1 2026 Earnings Call - Record U.S. Buyout Realizations Drive Fee Growth Amid Global Uncertainty
The Carlyle Group reported a strong first quarter of 2026, driven by record U.S. buyout realizations exceeding $12 billion, fee-related earnings of $300 million, and a 47% margin. Management highlight...
- Record U.S. buyout realizations of more than $12 billion, the highest quarterly level in firm history, with nearly $7 billion returned to U.S. buyout investors alone.
- Fee-related earnings reached $300 million in Q1 2026, representing a 47% margin and a 4% year-over-year increase in fund management fees to $545 million.
- Carlyle secured a $5 billion commitment for its next U.S. buyout fund through a novel, first-of-its-kind investment solution combining primary fund access with tailored liquidity via AlpInvest's portfolio finance and secondaries platforms.
- +7 more takeaways
Medline Industries Q1 2026 Earnings Call - Raised Sales Guidance Amid Tariff Headwinds and Middle East Uncertainty
Medline Industries kicked off 2026 with an 11% top-line growth rate, driven by a record quarter in Supply Chain Solutions and the continued ramp of $2.4 billion in new customer signings from 2025. The...
- Medline reported Q1 2026 net sales of $7.4 billion, up 11% year-over-year, driven by strong performance in Supply Chain Solutions which grew 15%.
- The company raised its full-year 2026 organic sales growth guidance to 8.5%–9.5%, up from the previous range of 8%–9%, citing solid same-store sales and procedural volume growth.
- Adjusted EBITDA declined 11% to $776 million, with margins contracting 250 basis points to 11% due to $85 million in incremental tariff costs and strategic operational investments.
- +9 more takeaways
"GoodRx" Q1 2026 Earnings Call - Pharma Direct Scales as Core Business Stabilizes
GoodRx delivered a strong first quarter in 2026, driven by an 82% year-over-year surge in Pharma Direct revenue, which now accounts for a significant and growing share of the company's total revenue. ...
- Pharma Direct revenue exploded 82% year-over-year to $52.2 million, validating the strategic pivot to manufacturer-sponsored direct-to-consumer pricing programs.
- The Wegovy pill launch was a massive success, with GoodRx capturing approximately one-third of all transactions in the first two months post-launch.
- Core prescription transaction revenue declined 24% year-over-year, but monthly active consumers flattened sequentially at 5.3 million, suggesting the worst of the erosion may be behind the company.
- +7 more takeaways